<?xml version="1.0" encoding="UTF-8"?>
<p id="p0005">In response to the coronavirus 2019 (COVID-19) pandemic, an overwhelming number of clinical trials have been registered to test a variety of preventive and therapeutic strategies, as comprehensively summarized by Lythgoe and Middleton [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. Under such an urgent circumstance, the quality of these clinical studies is inevitably of serious concern. Here, we propose applying prospective meta-analysis approaches to maximize their values, and to minimize research waste and bias of the ongoing and future COVID-19 trials.
</p>
